Accelerated pacing for right heart failure with severe tricuspid leak
Part of Heart & circulation clinical trials.
This trial tests a special pacing treatment for people with right-sided heart failure and a severe leak in the tricuspid valve. It aims to see if a faster pacing method can improve heart function and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your resting heart rate is 65 beats per minute or slower, confirmed by an EKG.
- You have right-sided heart failure that needs two or more daily doses of water pills to control swelling, or you still have some swelling even with those pills.
- An ultrasound of your heart shows a severe leak in the tricuspid valve.
- You may or may not already need a permanent pacemaker.
- You are not taking certain heart rate-lowering medicines (like beta-blockers, digoxin, or ivabradine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This study compares newer pacemaker types to see how well they work and how they affect your heart's pumping ability and valve function over a short period. You'll be monitored closely with heart imaging to understand which pacemaker performs best.
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
This trial tests whether a special pacing pattern can strengthen your heart's pumping ability. You may qualify if you have heart failure with a low ejection fraction and already have a pacemaker or defibrillator with an atrial lead.
This study looks at how a new pacemaker or defibrillator (CIED) might affect the tricuspid valve and the right side of the heart. It aims to understand these changes over time.
Hear when a new Right Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.